angiodesign.com | AngioDesign - ACE Targeted Molecular

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php

Meta Tags

Title	AngioDesign - ACE Targeted Molecular
Description	Welcome to AngioDesign is using 3-D structure-guided design to synthesize a new class of domain-selective ACE inhibitors for cardiovascular and other non-communicable
Keywords	N/A

Server Information

WebSite	angiodesign.com
Host IP	197.221.14.40
Location	South Africa

Related Websites

                        Site
                        Rank
                    

More to Explore

angiodesign.com Valuation

US$1,274

Last updated: 2022-07-11 20:42:37

angiodesign.com has Semrush global rank of 0. angiodesign.com has an estimated worth of US$ 1,274, based on its estimated Ads revenue. angiodesign.com receives approximately 147 unique visitors each day. Its web server is located in South Africa, with IP address 197.221.14.40. According to SiteAdvisor, angiodesign.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,274
Daily Ads Revenue	US$1
Monthly Ads Revenue	US$35
Yearly Ads Revenue	US$423
Daily Unique Visitors	9
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
angiodesign.com.	A	7196	IP: 197.221.14.40
angiodesign.com.	NS	7200	NS Record: ns2.host-h.net.
angiodesign.com.	NS	7200	NS Record: ns1.host-h.net.
angiodesign.com.	NS	7200	NS Record: ns1.dns-h.com.
angiodesign.com.	MX	7200	MX Record: 10 mail.angiodesign.com.
angiodesign.com.	TXT	7200	TXT Record: google-site-verification=Zrkkr5hGHaUHofhcxuhYYQwGKYwmZWYLVI98hB0F6ms
angiodesign.com.	TXT	7200	TXT Record: v=spf1 mx a include:spf.host-h.net ?all

HtmlToTextCheckTime:2022-07-11 20:42:37

Home About Us Our Science News Contact Us Select Page Welcome to AngioDesign Our first target is Angiotensin-Converting Enzyme (ACE). AngioDesign is using 3-D structure-guided design to synthesize a new class of domain-selective ACE inhibitors for cardiovascular and other non-communicable diseases. Learn More Targeted Molecular Recognition Next-generation innovation combining clinical safety and efficacy Differentiation – first-in-class dual C-domain/NEP inhibitors with blockbuster potential to treat heart failure We have a well-differentiated alternative to Entresto The combination of a C-domain-selective ACEi plus an NEP inhibitor: Decreases blood pressure and normalises contraction of the blood vessels without influencing vascular permeability and endothelial cell function These features may be beneficial in the treatment of high blood pressure but without the side effects of cough and angioedema associated with the inhibition of NEP and the non-domain-selective inhibition of ACE

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Sun, 31 Oct 2021 13:35:34 GMT
Server: Apache
X-Redirect-By: WordPress
Upgrade: h2,h2c
Connection: Upgrade
Location: https://angiodesign.com/
Content-Type: text/html; charset=UTF-8

HTTP/2 200 
date: Sun, 31 Oct 2021 13:35:36 GMT
server: Apache
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
content-type: text/html; charset=UTF-8

angiodesign.com Whois Information

Domain Name: ANGIODESIGN.COM
Registry Domain ID: 87398959_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.tucows.com
Registrar URL: http://www.tucows.com
Updated Date: 2021-05-12T04:33:37Z
Creation Date: 2002-06-10T15:06:17Z
Registry Expiry Date: 2022-06-10T15:06:17Z
Registrar: Tucows Domains Inc.
Registrar IANA ID: 69
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS1.DNS-H.COM
Name Server: NS1.HOST-H.NET
Name Server: NS2.HOST-H.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-18T23:24:53Z <<<

angiodesign.com valuation and analysis